Upstate Active Clinical Trials Seeking Participants
Autologous Hematopoietic Stem Cell Transplantation After Melphalan with or without Total Body Irradiation for Multiple Myeloma.
What is the purpose of the study?
To provide autologous transplantation for patients with mulitiple myeloma.
Who is eligible?
Diagnosis of multiple myeloma, acceptable laboratory values, HIV negative, no serious or uncontrolled organ dysfunction.
What is involved if I participate?
- How long is the study?
Inpatient stay approximately 21days, followed for lifetime
- Is transportation provided or reimbursed?
- Is parking provided or reimbursed?
- What tests and procedures are involved?
Detailed history & physical to determine eligibility, laboratory tests, x-rays/scans, as necessary, bone marrow biopsy & aspirate as necessary, laboratory tests during hospital admission, dental clearance prior to transplant.
Who is the doctor administering the study?
Teresa C. Gentile, M.D., Ph.D.
Where will the study take place?
SUNY Upstate Medical University, Syracuse, NY
Over what time period is the study scheduled to run?
Who can I contact for more information?
- Name: Joanne M. Chilton, CCRP
- Phone: (315) 464-8240
- Email: email@example.com
- Fax: (315) 464-8274 or (315) 464-8289
If you are interested in this trial, please contact the study coordinator or investigator noted above.